LENZ Therapeutics (LENZ) News Today $31.36 -0.12 (-0.38%) As of 07/8/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LENZ Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in CanadaJuly 7 at 8:00 AM | globenewswire.comLENZ Therapeutics: Presbyopia Eyedrops Look PromisingJuly 1, 2025 | seekingalpha.comLENZ Therapeutics Inc Dividends - MorningstarJuly 1, 2025 | morningstar.comMLisanti Capital Growth LLC Purchases New Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)June 30, 2025 | marketbeat.comBrokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $46.60June 29, 2025 | americanbankingnews.comLENZ - LENZ Therapeutics Inc Trailing Returns - MorningstarJune 28, 2025 | morningstar.comMLENZ Therapeutics Inc Financials - MorningstarJune 27, 2025 | morningstar.comMLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Buy" by BrokeragesJune 26, 2025 | marketbeat.comVersant sells LENZ therapeutics (LENZ) stock worth $10.1 millionJune 22, 2025 | investing.comLENZ Therapeutics: Ready To Test Its PotentialJune 16, 2025 | seekingalpha.comLENZ Therapeutics (NASDAQ:LENZ) Shares Up 6.3% - Here's WhyJune 11, 2025 | marketbeat.comTwo Sigma Investments LP Has $493,000 Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)June 10, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Shares Down 5.9% - Here's What HappenedJune 9, 2025 | marketbeat.comBank of America Corp DE Boosts Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)June 7, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Buy" by AnalystsJune 1, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Holdings Decreased by Ameriprise Financial Inc.June 1, 2025 | marketbeat.comLENZ Therapeutics May 2025 slides: presbyopia treatment nears FDA decisionMay 29, 2025 | uk.investing.comRafferty Asset Management LLC Purchases Shares of 17,716 LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 25, 2025 | marketbeat.comNorthern Trust Corp Raises Stock Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 25, 2025 | marketbeat.comDelta Investment Management LLC Takes $555,000 Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 22, 2025 | marketbeat.comPoint72 Asset Management L.P. Reduces Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 19, 2025 | marketbeat.comParadigm Biocapital Advisors LP Purchases New Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 16, 2025 | marketbeat.comGranahan Investment Management LLC Buys Shares of 51,842 LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 13, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Acquires 36,582 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 13, 2025 | marketbeat.comLeerink Partnrs Analysts Raise Earnings Estimates for LENZMay 13, 2025 | marketbeat.comHC Wainwright Issues Negative Estimate for LENZ EarningsMay 13, 2025 | marketbeat.comQ2 EPS Forecast for LENZ Therapeutics Raised by AnalystMay 13, 2025 | marketbeat.comLENZ and Lotus Pharmaceutical collaborate to commercialise presbyopia treatmentMay 12, 2025 | msn.comLENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comHC Wainwright Reiterates "Buy" Rating for LENZ Therapeutics (NASDAQ:LENZ)May 10, 2025 | marketbeat.comEarnings call transcript: LENZ Therapeutics’ Q1 2025 results show innovation driveMay 9, 2025 | uk.investing.comLENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast AsiaMay 9, 2025 | globenewswire.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Rating of "Buy" by BrokeragesMay 9, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Bought by Alyeska Investment Group L.P.May 8, 2025 | marketbeat.comBarclays PLC Increases Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 8, 2025 | marketbeat.comLENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 7, 2025 | globenewswire.comLENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care ConferenceMay 6, 2025 | globenewswire.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Purchased by Price T Rowe Associates Inc. MDMay 4, 2025 | marketbeat.comRenaissance Technologies LLC Sells 23,900 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 4, 2025 | marketbeat.comSamsara BioCapital LLC Lowers Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)May 2, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Position Lessened by Boothbay Fund Management LLCMay 1, 2025 | marketbeat.comLENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025April 30, 2025 | globenewswire.comRock Springs Capital Management LP Acquires New Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)April 23, 2025 | marketbeat.comLENZ Therapeutics' (LENZ) Buy Rating Reiterated at HC WainwrightApril 18, 2025 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: 908 Devices (MASS), LENZ Therapeutics (LENZ) and Johnson & Johnson (JNJ)April 17, 2025 | markets.businessinsider.comLENZ Therapeutics (NASDAQ:LENZ) Shares Gap Up - Should You Buy?April 17, 2025 | marketbeat.comBank of America Securities Keeps Their Buy Rating on LENZ Therapeutics (LENZ)April 17, 2025 | markets.businessinsider.comLENZ Therapeutics (LENZ) Receives a Buy from TD CowenApril 17, 2025 | markets.businessinsider.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Up 8.3% - Still a Buy?April 16, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Now Covered by Analysts at Piper SandlerApril 16, 2025 | marketbeat.com Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address LENZ Media Mentions By Week LENZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LENZ News Sentiment▼0.610.57▲Average Medical News Sentiment LENZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LENZ Articles This Week▼13▲LENZ Articles Average Week Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MLTX News Today MTSR News Today VKTX News Today KYMR News Today MOR News Today CRNX News Today ALVO News Today IMVT News Today CPRX News Today HCM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LENZ) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
